Age Distribution and Yearly Changes in the Incidence of ESRD in Japan

American Journal of Kidney Diseases

Volumn 43, Issue 3, 2004, Pages 433-443

  Yamagata, Kunihiro ^a   Takahashi, Hideto ^b   Suzuki, Soh ^b   Mase, Kaori ^b   Hagiwara, Masahiro ^b   Shimizu, Yoshio ^b   Hirayama, Kouichi ^b   Kobayashi, Masaki ^b   Narita, Mitsuharu ^b   Koyama, Akio ^b  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b NONE

Author keywords

Aging; End stage renal disease (ESRD); Incidence; Mass screening; Urinalysis

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; AGING; ARTICLE; CAUCASIAN; DIABETES MELLITUS; GLOMERULONEPHRITIS; HEALTH PROGRAM; HUMAN; HYPERTENSION; INCIDENCE; JAPAN; KIDNEY DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MASS SCREENING; PREVALENCE; RACE DIFFERENCE; UNITED STATES; URINALYSIS;

EID: 10744226577     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2003.11.005     Document Type: Article

References (37)

1. Jungers P: Screening for renal insufficiency: Is it worth while? Is it feasible? Nephrol Dial Transplant 14:2082-2084, 1999
2. Akiba T, Nakai S, Shinzato T, et al: Why has the gross mortality of dialysis patients increased in Japan? Kidney Int Suppl 74:S60-S65, 2000
3. Obrador GT, Arora P, Kausz AT, Pereira BJ: Pre-end-stage renal disease care in the United States: A state of disrepair. J Am Soc Nephrol 9:S44-S54, 1998 (suppl 4)
4. Iglehart JK: The American health care system. The End Stage Renal Disease Program. N Engl J Med 328:366-371, 1993
5. Tiebosch ATMG, Wolters J, Frederik PFM. van der Wiel TWM, Zeppenfeldt E, van Breda Vriesman PJC: Epidemiology of idiopathic glomerular disease: A prospective study. Kidney Int 32:112-116, 1987
6. Simon P, Ramee MP, Autuly V, et al: Epidemiology of primary glomerular diseases in a French region. Variations according to period of age. Kidney Int 46:1192-1198, 1994
7. Yamagata K, Takahashi H, Tomida C, Yamagata Y, Koyama A: Prognosis of asymptomatic hematuria and/or proteinuria in men. Nephron 91:34-42, 2002
8. Ishida K, Ishida H, Narita M, et al: Factors affecting renal function in 119 985 adults over three years. Q J Med 94:541-550, 2001
9. Kitagawa T: Lessons learned from the Japanese nephritis screening study. Pediatr Nephrol 2:256-263, 1988
10. Jungers P: Late referral: Loss of chance for the patient, loss of money for society. Nephrol Dial Transplant 17:371-375, 2002
11. Schena FP: Epidemiology of end-stage renal disease: International comparisons of renal replacement therapy. Kidney Int Suppl 74:S39-S45, 2000
12. US Renal Data System: Excerpts from the 2001 Annual Data Report: Atlas of end-stage renal disease in the United States. Am J Kidney Dis 38:195-200, 2001
13. Nakai S, Shinzato T, Sanaka T, et al: An overview of dialysis treatment in Japan. J Jpn Soc Dial Ther 34:1121-1147, 2001
14. Ministry of Public Management, Home Affairs, Posts and Telecommunications: Japan Statistical Yearbook 2001. Tokyo, Japan, Ministry of Public Management, Home Affairs, Posts and Telecommunications, 2001
15. Maisonneuve P, Agodoa L, Gellert R, et al: Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: Results from an international comparative study. Am J Kidney Dis 35:157-165, 2000
16. Shinzato T, Nakai S, Akiba T, et al: Report of the annual statistical survey of the Japanese Society for Dialysis Therapy in 1996. Kidney Int 55:700-712, 1999
17. Yamagata K, Yamagata Y, Kobayashi M, Koyama A: A long-term follow-up study of asymptomatic hematuria and/or proteinuria in adults. Clin Nephrol 45:281-288, 1996
18. Woothandler S, Pels RJ, Bor DH, Himmelstein DU, Lawrence RS: Dipstick urinalysis screening of asymptomatic adults for urinary tract disorders. I. Hematuria and proteinuria. JAMA 262:1214-1219, 1989
19. Stewart JH, McCredie M, Disney AP, Mathew TH: Trends in incidence of end-stage renal failure in Australia, 1972-1991. Nephrol Dial Transplant 9:1377-1382, 1994
20. Nagai R, Wang EEL, Feldman W: Dipstick proteinuria screening of asymptomatic adults to prevent progressive renal disease, in Canadian Task Force on the Periodic Health Examination. Ottawa, Canada, Health Canada, 1994, pp 436-445
21. Klahr S, Levey AS, Beck GJ, et al: The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 330:877-884, 1994
22. Heart Outcomes Prevention Evaluation Study Investigators: Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy. Lancet 355:253-259, 2000
23. Parving HH, Lehnert H, Brochner-Mortensen J, et al: The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 345:870-878, 2001
24. Brenner BM, Cooper ME, de Zeeuw D, et al: Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345:861-869, 2001
25. Hebert LA, Wilmer WA, Falkenhain ME, Ladson-Wofford SE, Nahman NS, Rovin BH: Renoprotection: One or many therapies? Kidney Int 59:1211-1226, 2001
26. Yoshikawa N, Ito H, Sakai T, et al. A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. The Japanese Pediatric IgA Nephropathy Treatment Study Group. J Am Soc Nephrol 10:101-109, 1999
27. Iitaka K, Sakai T, Yagiswa K, Aoki Y: Decreasing hypocomplementemia and membranoproliferative glomerulonephritis in Japan. Pediatr Nephrol 14:794-796, 2000
28. Braden GL, Mulhern JG, O'Shea MH, Nash SV, Ucci AA, Germain MJ: Changing incidence of glomerular diseases in adults. Am J Kidney Dis 35:878-883, 2000
29. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
30. Bojestig M, Arnqvist HJ, Hermansson G, Karlberg BE, Ludvigsson J: Declining incidence of nephropathy in insulin-dependent diabetes mellitus. N Engl J Med 330:15-18, 1994
31. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group: Retinopathy and nephropathy in patients with type 1 diabetes four years alter a trial of intensive therapy. N Engl J Med 342:381-389, 2000
32. Wang PH, Lau J, Chalmers TC: Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes. Lancet 341:1306-1309, 1993
33. Matsushima M, Tajima N, LaPorte RE, et al: Markedly increased renal disease mortality and incidence of renal replacement therapy among IDDM patients in Japan in contrast to Allegheny County, Pennsylvania, USA. Diabetes Epidemiology Research International (DERI) U.S.-Japan Mortality Study Group. Diabetologia 38:236-243, 1995
34. Keenan HT, Foster CM, Bartton SL: Social factors associated with prolonged hospitalization among diabetic children. Pediatrics 109:40-44, 2002
35. Diabetes Epidemiology Research International Mortality Study Group: International evaluation of cause-specific mortality and IDDM. Diabetes Care 14:55-60, 1991
36. Japanese Society for Dialysis Therapy: An Overview of Regular Dialysis Treatment in Japan as of December 31, 1999. Tokyo, Japan, Japanese Society for Dialysis Therapy, 2000
37. Sekkarie MA, Moss AH: Withholding and withdrawing dialysis: The role of physician specialty and education and patient functional status. Am J Kidney Dis 31:464-472, 1998